Abbott Laboratories (ABT) Debt to Equity (2009 - 2026)
Abbott Laboratories recorded quarterly Debt to Equity of $0.65 in Q1 2026, up 166.93% quarter-over-quarter from $0.25 in Q4 2025, and up 135.65% year-over-year from $0.28 in Q1 2025.
Abbott Laboratories' Debt to Equity history runs 18 years deep, the most recent figure standing at $0.65 for Q1 2026.
- In Q1 2026, Debt to Equity rose 135.65% year-over-year to $0.65; the TTM figure through Mar 2026 stood at $0.65 (up 135.65% YoY), while the FY2025 annual figure was $0.25, down 99.64% from the prior year.
- Debt to Equity came in at $0.65 for Q1 2026 at Abbott Laboratories, up from $0.25 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $358.02 in Q4 2023 to a low of -$624.12 in Q3 2024.
- A 5-year average of $5.69 and a median of $0.28 in 2025 frame the typical range for Debt to Equity.
- Across the five-year window, Debt to Equity jumped 52642.05% in 2023 and plunged 33984.11% in 2024, its largest moves.
- Abbott Laboratories' Debt to Equity stood at $0.68 in 2022, then surged by 52642.05% to $358.02 in 2023, then sank by 81.21% to $67.26 in 2024, then slumped by 99.64% to $0.25 in 2025, then surged by 166.93% to $0.65 in 2026.
- According to Business Quant data, Debt to Equity over the past three periods registered $0.65, $0.25, and $0.25 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.65 |
| Dec 31, 2025 | 0.25 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | 0.28 |
| Dec 31, 2024 | 67.26 |
| Sep 30, 2024 | -624.13 |
| Jun 30, 2024 | 94.58 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 358.02 |
| Sep 30, 2023 | -1.83 |
| Jun 30, 2023 | -11.25 |
| Mar 31, 2023 | -2.10 |
| Dec 31, 2022 | 0.68 |
| Sep 30, 2022 | -1.13 |
| Jun 30, 2022 | -1.93 |
| Mar 31, 2022 | 216.33 |
| Dec 31, 2021 | 81.31 |
| Sep 30, 2021 | 84.26 |
| Jun 30, 2021 | -3.39 |
| Mar 31, 2021 | -1.80 |
| Dec 31, 2020 | 0.67 |
| Sep 30, 2020 | -5.37 |
| Jun 30, 2020 | 0.76 |
| Mar 31, 2020 | -1.82 |
| Dec 31, 2019 | -2.12 |
| Sep 30, 2019 | -1.96 |
| Jun 30, 2019 | 0.77 |
| Mar 31, 2019 | 0.77 |
| Dec 31, 2018 | -2.58 |
| Sep 30, 2018 | -8.07 |
| Jun 30, 2018 | -2.05 |
| Mar 31, 2018 | -186.73 |
| Dec 31, 2017 | 1.16 |
| Sep 30, 2017 | -6.34 |
| Jun 30, 2017 | 1,831.77 |
| Mar 31, 2017 | -1,584.47 |
| Dec 31, 2016 | -2.85 |
| Sep 30, 2016 | -3.03 |
| Jun 30, 2016 | -1.33 |
| Mar 31, 2016 | -17.96 |
| Dec 31, 2015 | 0.23 |
| Sep 30, 2015 | -9.25 |
| Jun 30, 2015 | -1.62 |
| Mar 31, 2015 | 50.87 |
| Dec 31, 2014 | -0.68 |
| Sep 30, 2014 | 0.35 |
| Jun 30, 2014 | 0.14 |
| Mar 31, 2014 | 0.15 |
| Dec 31, 2013 | 68.25 |
| Sep 30, 2013 | 0.34 |
| Jun 30, 2013 | 0.34 |
| Mar 31, 2013 | 0.17 |
| Dec 31, 2012 | -3.29 |
| Sep 30, 2012 | 0.48 |
| Jun 30, 2012 | 0.53 |
| Mar 31, 2012 | 0.50 |
| Dec 31, 2011 | 167.30 |
| Sep 30, 2011 | 0.68 |
| Jun 30, 2011 | 0.48 |
| Mar 31, 2011 | 0.70 |
| Dec 31, 2010 | 1.93 |
| Sep 30, 2010 | 0.71 |
| Jun 30, 2010 | 0.82 |
| Dec 31, 2009 | -3.47 |
| Sep 30, 2009 | 0.54 |
| Jun 30, 2009 | 0.57 |